Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Irish Pharmaceutical Healthcare Association .
Filed returns
19
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2025 | Irish Pharmaceutical Healthcare Association | Health | New framework Agreement on the Pricing and Supply of Medicines. (Matters involving public funds) | 4 | On lobbying.ie |
| Sep–Dec 2025 | Irish Pharmaceutical Healthcare Association | Health | New framework Agreement on the Pricing and Supply of Medicines. (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | Future Framework Agreement - issues concerning timely reimbursement of medicines in Ireland. (Legislation) | 10 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | US Tariffs and EU - Irish Response (Matters involving public funds) | 8 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | (i) EU General Pharmaceutical Legislation and Irish Government position on Intellectual Property Rights. (ii) EU and Irish competitiveness and the pharmaceutical industry. (Legislation) | 6 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | Future Framework Agreement (Legislation) | 6 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | US Tariffs and EU - Irish Response (Public policy or programme) | 8 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | Future Framework Agreement - issues concerning timely reimbursement of medicines in Ireland. (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2025 | Irish Pharmaceutical Healthcare Association | Health | (i) Proposed revision of EU General Pharmaceutical Legislation and Irish Government position on intellectual Property rights; (ii) Industry position on a National Life Sciences Strategy; (iii) EU and Irish… (Legislation) | 4 | On lobbying.ie |
| Jan–Apr 2025 | Irish Pharmaceutical Healthcare Association | Health | (i) Proposed revision of EU General Pharmaceutical Legislation and Irish Government position on intellectual Property rights; (ii) Industry position on a National Life Sciences Strategy; (iii) EU and Irish… (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2024 | Irish Pharmaceutical Healthcare Association | Health | (i) Proposed revision of EU General Pharmaceutical Legislation, particularly items relating to incentives/intellectual property rights; (ii) EU wide access to new medicines. (Legislation) | 10 | On lobbying.ie |
| Jan–Apr 2024 | Irish Pharmaceutical Healthcare Association | Health | (1) Budget 2024 - the need for funding of new medicines. (2) Likely no provision for new developments funding to HSE for new medicines in Budget 2024. (3) Absence of funding for new medicines in Budget 2024. (4)… (Matters involving public funds) | 34 | On lobbying.ie |
| Jan–Apr 2023 | Irish Pharmaceutical Healthcare Association | Health | Agenda of the EU Competitiveness Council (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2023 | Irish Pharmaceutical Healthcare Association | Health | Revision of pharmaceutical legislation by European Commission. (Legislation) | 9 | On lobbying.ie |
| Jan–Apr 2023 | Irish Pharmaceutical Healthcare Association | Health | Revision of pharmaceutical legislation by European Commission. (Legislation) | 10 | On lobbying.ie |
| Sep–Dec 2022 | Irish Pharmaceutical Healthcare Association | Health | Congratulations on appointment. Seek support for fast access to new medicines and for innovation in the EU Pharmaceutical Strategy. (Public policy or programme) | 6 | On lobbying.ie |
| Jan–Apr 2019 | Irish Pharmaceutical Healthcare Association | Health | To highlight importance of continuity of supply of medicines in Europe post Brexit (Public policy or programme) | 5 | On lobbying.ie |
| Sep–Dec 2018 | Irish Pharmaceutical Healthcare Association | Health | IPHA 'Manifesto for Better Health' (Public policy or programme) | 25 | On lobbying.ie |
| Sep–Dec 2018 | Irish Pharmaceutical Healthcare Association | Health | Inclusion of medicine regulation in Brexit withdrawal agreement (Public policy or programme) | 3 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 19 | 100.0% |